1 min read
Eli Lilly to Buy Calytrix Bio in All-Cash Deal Worth Up to $1.5 Billion
Calytrix Bio is a privately held biotechnology company, and the transaction is structured as an all-cash deal.

Eli Lilly will buy privately held biotechnology company Calytrix Bio in an all-cash deal with a maximum stated value of $1.5 billion.